More subjects on NeuroAiD™ improved to functional independence compared to placebo among subjects receiving rehabilitation up to 3 months after an acute ischemic stroke. The Continue Reading
admin
Editorial administrator
China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share
TAIZHOU, China, Sept. 29, 2018 /PRNewswire/ — China SXT Pharmaceuticals, Inc. (the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and Continue Reading
Global rotavirus vaccine options expand with World Health Organization prequalification of new vaccine from India
-Thermostable rotavirus vaccine ROTASIIL® now available for procurement by UN and Gavi SEATTLE, Sept. 28, 2018 /PRNewswire/ — PATH welcomes the World Health Organization’s (WHO’s) prequalification Continue Reading
Launch of Special Chinese Big Data Platform for Cancer Genomics Informatics to Accelerate Innovation and Development of China’s Precision Diagnosis and Treatment
SHANGHAI, Sept. 28, 2018 /PRNewswire/ — On September 21, 2018, the CSCO precision medicine international session with the theme of “All-Round Research by Experts for Continue Reading
VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board
ISNES, Belgium, Sept. 26 2018 /PRNewswire/ — VolitionRx Limited (NYSE American: VNRX) (“Volition”) today released a video featuring members of its Scientific Advisory Board (SAB). The video Continue Reading
Successful Launch of Merieux Participations 3, The New Growth Capital Fund of Merieux Equity Partners
LYON, France, Sept. 27, 2018 /PRNewswire/ — Merieux Equity Partners, a management company created by Merieux Developpement, announces the first closing of its third generation fund, Continue Reading
AGC to Establish Mammalian cGMP-Compatible Contract Facility for Biopharmaceutical Development and Production at Chiba Plant
TOKYO, Sept. 25, 2018 /PRNewswire/ — AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, will be establishing a cGMP (*1)-compatible mammalian cell culture Continue Reading
Medix Medical Monitor Survey Uncovers Singapore’s Health Concerns and Perceptions
Survey shows high fear of cancer, heart attacks and diabetes, with many Singaporeans pessimistic about their health status and unsure of the best place to Continue Reading
PharmaBlock appoints Dr. Shijie Zhang as Chief Technology Officer
NANJING, China, Sept. 20, 2018 /PRNewswire/ — PharmaBlock Sciences (Nanjing), Inc. (SZSE: 300725), a global leader in providing innovative chemistry products and services throughout the pharmaceutical Continue Reading
Noxopharm Subsidiary Announces Important Drug Discovery
SYDNEY, Sept. 24, 2018 /PRNewswire/ — New family of drug candidates inhibit the ‘master switch’ involved in inflammation and autoimmunity Able to cross the blood-brain Continue Reading